Top Most 7+ When Will Ocugen Get Fda Approval
-
1.Ocugen COVID Shot Will Have To Wait For US Market As FDA Slaps Clinical Hold On Phase 3 Trial
It was a black Friday indeed for Ocugen, which revealed in the early morning hours after Thanksgiving that the FDA placed a clinical hold on its COVID-19 vaccine. | It was a black Friday indeed for Ocugen, which revealed in the early morning hours after Thanksgiving that the FDA placed a clinical hold on its COVID-19 vaccine.
View more » -
2.FDA Lifts Hold On Ocugen's COVID-19 Vaccine Trial. But Is It Too Late For The Shot?
Six weeks after slapping a clinical hold on a trial of Ocugen’s COVID-19 vaccine, the FDA has li | Six weeks after slapping a clinical hold on a trial of Ocugen’s COVID-19 vaccine, the FDA has lifted it. But given the declining demand for COVID shots, is the regulatory status of Covaxin bordering on irrelevance?
View more » -
3.FDA Slaps Another Hold On Ocugen, Bharat's COVID Vaccine After WHO Flags Manufacturing Problems
In April of last year—soon after receiving a $200 million government grant from India to beef up its manufacturing capacity—Bharat Biotech proclaimed an ambitious goal to produce 700 million COVID- | The FDA has put a clinical hold on a bridging study by Ocugen designed to show that its Bharat Biotech-partnered COVID-19 vaccine Covaxin can protect people in the U.S. as effectively as it has done in trials in India. It is the second clinical hold in five months for Ocugen's application for approval.
View more » -
4.Ocugen: Latest News & Videos, Photos About Ocugen | The Economic Times - Page 1
ocugen Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. ocugen Blogs, Comments and Archive News on Economictimes.com
View more » -
5.Events - Ocugen
-
6.Ocugen Inc. - Clinical-Stage Biotechnology
Ocugen, develops novel solutions to medical challenges, to deliver new breakthroughs for people living with disease.
View more » -
7.Ocugen: FDA Lifts Hold As Shares Sink - Worth Staying The Course? (NASDAQ:OCGN)
The FDA has finally lifted its clinical hold of Ocugen's IND submission for the COVID vaccine COVAXIN. Read more to see what this means for OCGN stock.
View more »